Md Salman Ashrafi

About Author:

SOCIAL LINK:

Salman brings over three years of experience in uncovering stories behind startups and economic trends. With a solid background in finance and research, he’s passionate about decoding business models and analyzing stocks.

Blogs by Md Salman Ashrafi

Reliance Q4 Results Are Out! Stock Up 5%

Reliance Q4 FY25 Results: Posts 10% Revenue Growth, Stock Jumps 5%

Reliance Q4 Results & Earnings FY25 - Revenue grows 10%, profit surges 6%. After result announcement, Reliance stock price rose 5%. Get financial highlights at INDmoney.

Md Salman Ashrafi

Published in Stocks

a year ago

Innovision IPO Allotment Status: KFinTech, BSE, NSE

Innovision IPO Allotment Status: Check on KFinTech, BSE, NSE

Check Innovision IPO allotment status on KFinTech, BSE, and NSE. See final subscription, GMP trend, extension, and price cut impact, and what to expect on listing day.

Md Salman Ashrafi

Published in IPO

5 days ago

Vikran Engineering IPO: All You Need to Know

Vikran Engineering IPO Subscribed 5.5x on Day 2; Retail, HNIs Drive Demand as GMP Weakens

Vikran Engineering IPO Day 2 update: Subscription surges 5.5x led by retail and NIB demand, while GMP cools to ₹12. Read insights on demand, grey market trend, positives, and risks.

Md Salman Ashrafi

Published in IPO

7 months ago

Capillary Technologies IPO: Invest or Avoid?

Capillary Technologies IPO Review, GMP, Valuation - Invest or Avoid?

A detailed review of Capillary Technologies IPO - GMP trend, risks, strengths, valuation analysis, peer comparison, and analyst view, to help you make an informed decision.

Md Salman Ashrafi

Published in IPO

4 months ago

Innovision IPO Review: GMP, Valuation, Strengths & Risks

Innovision IPO Review: Everything You Need to Know About the ₹323 Cr Issue

Innovision IPO opens March 10-12, 2026, at ₹521-₹548. Read our fact-based review covering business model, financials, risks, peer comparison, and analyst view.

Md Salman Ashrafi

Published in IPO

13 days ago